Mergers & Acquisitions - Bristol-Myers Squibb, Biotechnology


Popular Filters

Bristol-Myers enters option deal to acquire F-star Alpha and FS102


US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones

Bristol-Myers acquires iPierian for $175 million upfront, plus $550 possible milestones


US pharma major Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused…

BiotechnologyBristol-Myers SquibbiPierianIPN007Mergers & AcquisitionsNeurological

Synergy Pharma gains rights to shingles drug from Bristol-Myers


US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

Amylin seduced by $5.3 billion bid from Bristol-Myers; AstraZeneca chips in for share of the action


Having rejected a media reported $22 a share offer from the company earlier this year, US biotech firm…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbBydureonByettaDiabetesEli LillyMergers & AcquisitionsPharmaceutical

Amylin said to be attracting several Big Pharma suitors


US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22 per share…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbMerck & CoMergers & AcquisitionsPfizerPharmaceuticalRocheSanofiTakeda Pharmaceuticals

Investor Icahn slams Amylin for not revealing B-MS bid


Billionaire US investor Carl Icahn has sent a blistering open letter to the board of US biotech company…

AmylinBiotechnologyBristol-Myers SquibbMergers & AcquisitionsPharmaceutical

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis


There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals



Back to top